Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Symeonidis

Showing results (511-520 of 578) with videos related to

Pageof 58
Sort By:
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
Blood Advances|June 21, 2022
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AMLLionel Adès, Larisa Girshova, Vadim A Doronin, et al.
Nature Communications|January 13, 2026
A centrally positioned cluster of multiple centrioles in antigen-presenting cells fosters T cell activationIsabel Stötzel, Ann-Kathrin Weier, Apurba Sarkar, et al.
American Journal of Hematology|June 10, 2024
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myelomaSosana Delimpasi, Meletios A Dimopoulos, Jan Straub, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Advantages and Limitations of Ultrasound as a Screening Test for Ovarian CancerAntonios Koutras, Paraskevas Perros, Ioannis Prokopakis, et al.
Leukemia Research|May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
Leukemia|March 19, 2014
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myelomaE Kastritis, F Zagouri, A Symeonidis, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
American Journal of Hematology|January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trialEvangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Scientific Reports|October 26, 2022
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndromePanagiotis T Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, et al.
Pageof 58

Showing results (511-520 of 578) with videos related to

Sort By:
Pageof 58
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
Blood Advances|June 21, 2022
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AMLLionel Adès, Larisa Girshova, Vadim A Doronin, et al.
Nature Communications|January 13, 2026
A centrally positioned cluster of multiple centrioles in antigen-presenting cells fosters T cell activationIsabel Stötzel, Ann-Kathrin Weier, Apurba Sarkar, et al.
American Journal of Hematology|June 10, 2024
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myelomaSosana Delimpasi, Meletios A Dimopoulos, Jan Straub, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Advantages and Limitations of Ultrasound as a Screening Test for Ovarian CancerAntonios Koutras, Paraskevas Perros, Ioannis Prokopakis, et al.
Leukemia Research|May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
Leukemia|March 19, 2014
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myelomaE Kastritis, F Zagouri, A Symeonidis, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
American Journal of Hematology|January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trialEvangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Scientific Reports|October 26, 2022
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndromePanagiotis T Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, et al.
Pageof 58